Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON Block and Trigger Point Injection for Neck Pain
NCT07058636Recruiting
- Sponsor
- Ankara Etlik City Hospital
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of betamethasone in myofascial pain syndrome (MPS) and Cervicalgia (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Visual Analog Scale at 4 weeks. Started Apr 2025; status: recruiting.
02
Drugs
betamethasone
03
Conditions
myofascial pain syndrome (MPS)Cervicalgia
Beyond the preview
Go deeper on NCT07058636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07058636.